by Bhavani Srinivasan | Oct 28, 2022 | Newsletters
As the COVID pandemic started, expectations in the “access to medicines” community raised. After all, if a pandemic could not build the case for equitable access to vaccines and medicines, what would? Yet, initial promises, such as Von der Leyen’s commitment to... by Bhavani Srinivasan | Sep 29, 2022 | Newsletters
Times of crisis call for well-considered, but bold responses. It is not an option to retreat and wait out the storm. The storm seems only to be getting bigger. Things previously held impossible are happening one after the other. A global pandemic. War in Europe. An... by Bhavani Srinivasan | Aug 31, 2022 | Newsletters
Since the World Health Organisation’s Air Quality Guidelines’ publication in September 2021, the environmental and health communities have been active to explain why these guidelines are so important. They not only identify the levels of air quality necessary to... by Bhavani Srinivasan | Jul 20, 2022 | Newsletters
This month’s newsletter is dedicated to the European Commission’s proposal for a regulation to set up the European Health Data Space (EHDS), published on May 3rd, 2022. The EHDS regulation aims to provide a common framework across EU Member States for accessing and... by Bhavani Srinivasan | Jun 28, 2022 | Newsletters
Our June newsletter is dedicated to the window of opportunity offered by the ongoing revision of the EU’s pharmaceutical legislation to improve access to effective and affordable medicines for everyone. Contrary to what the pharmaceutical industry claims, high prices... by Bhavani Srinivasan | May 31, 2022 | Newsletters
This month’s newsletter shines a light on antimicrobial resistance (AMR), the global public health crisis recently reported as responsible for 1.27 million global deaths per year. Sadly, AMR is a major concern for health professionals, who are already struggling to...
